NEUROSENSE THERAPEUTICS LTD
NRSNNASDAQ🏆 #3977 by market capUS Equity
$0.47▼ $0.01 (−2.02%)
🌅 Pre-market$0.47▼ 0.30%Regular close · extended-hours price shown1h—
24h▼ 2.0%
7d▼ 13.6%
14d▼ 4.2%
30d▼ 33.4%
1y▼ 57.6%
🏦Market Cap
$17M
Small Cap
📈Revenue Growth (YoY)
—
📊Gross Margin
—
💵FCF Margin
—
⚖️P/S Ratio
—
Otter Score
64
Fair
Earnings
Q2 · 2025Reported 2025-06-30Earnings Per Share
Actual
-0.19
Expected
-0.20
beat
+6.90%
YoY −850.00%
Revenue
Actual
—
Expected
—
—
—
Consensus estimates
Recent quarters
Q2 2025
-0.19
beat
Q4 2024
-0.06
beat
Q3 2024
-0.11
beat
Q2 2024
-0.02
beat